MedTrace Logo

Indocyanine Green Fluorescence in Endoscopic Resection of Non-Functioning Pituitary Adenomas

NCT07763236 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 34

Last updated 2026-08-13

No results posted yet for this study

Summary

The goal of this study was to determine whether ICG improves outcomes in surgery for non-functioning macroadenomas. The main questions it aimed to answer were:

Was gross total resection more frequent? Did ICG use lead to fewer intraoperative and postoperative complications?

The investigators compared the ICG group with the control group to determine whether there were differences in outcomes between the groups.

Participants received ICG intraoperatively if they had been randomly assigned to the ICG group.

Conditions

  • Non-functioning Pituitary Adenoma

Interventions

PROCEDURE

Endoscopic endonasal transsphenoidal surgery

Endoscopic endonasal transsphenoidal resection of non-functioning pituitary macroadenomas.

DRUG

Indocyanine Green dye

Intravenous administration of indocyanine green during surgery to provide intraoperative fluorescence visualization during endoscopic resection of non-functioning pituitary macroadenomas.

Sponsors & Collaborators

  • Tomislav Felbabić

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-19
Primary Completion
2022-10-19
Completion
2023-03-25

Countries

  • Slovenia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07763236 on ClinicalTrials.gov